Jianghong Wang

Catalpol induces cell activity to promote axonal regeneration via the PI3K/AKT/mTOR pathway in vivo and in vitro stroke model.

Huifeng Zhu, Guoran Wan, Dong Wan, 2019, Annals of translational medicine.

Sunvozertinib for the treatment of NSCLC with EGFR Exon20 insertion mutations: The first pivotal study results.

Ying Cheng, Yanqiu Zhao, Yong He, 2023, Journal of Clinical Oncology.